Terms: = Lung cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
2217 results:
1. Exploring new frontiers: cell surface vimentin as an emerging marker for circulating tumor cells and a promising therapeutic target in advanced gastric cancer.
Li H; Zhu YZ; Xu L; Han T; Luan J; Li X; Liu Y; Wang Z; Liu Q; Kong X; Zou C; Su L; Hou Y; Chen X; Chen L; Wang R; Xu Z; Zhao M
J Exp Clin Cancer Res; 2024 Apr; 43(1):129. PubMed ID: 38685125
[TBL] [Abstract] [Full Text] [Related]
2. Treatment strategies for stage IA non-small cell lung cancer: A SEER-based population study.
Wu B; Zhang X; Feng N; Hu Z; Wu J; Zhou W; Wei Y; Zhang W; Wang K
PLoS One; 2024; 19(4):e0298470. PubMed ID: 38683794
[TBL] [Abstract] [Full Text] [Related]
3. The Evaluation and Management of lung Metastases in Patients with Giant Cell Tumors of Bone in the Denosumab Era.
Trovarelli G; Rizzo A; Cerchiaro M; Pala E; Angelini A; Ruggieri P
Curr Oncol; 2024 Apr; 31(4):2158-2171. PubMed ID: 38668063
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy and safety of neoadjuvant immunotherapy plus chemotherapy followed by adjuvant immunotherapy in resectable non-small cell lung cancer: a meta-analysis of phase 3 clinical trials.
Zhang W; Liang Z; Zhao Y; Li Y; Chen T; Li W; Chen Y; Wu P; Zhang H; Fang C; Li L
Front Immunol; 2024; 15():1359302. PubMed ID: 38646542
[TBL] [Abstract] [Full Text] [Related]
5. Effect of the STK11 mutation on therapeutic efficacy and prognosis in patients with non-small cell lung cancer: a comprehensive study based on meta-analyses and bioinformatics analyses.
Xu K; Lu W; Yu A; Wu H; He J
BMC Cancer; 2024 Apr; 24(1):491. PubMed ID: 38632512
[TBL] [Abstract] [Full Text] [Related]
6. Uncertainty among patients with advanced-stage lung cancer.
Wongkalasin K; Matchim Y; Kanhasing R; Pimvichai S
Int J Palliat Nurs; 2024 Apr; 30(4):160-169. PubMed ID: 38630643
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
8. Impact of immune checkpoint inhibitors (ICIs) therapy on interferon-γ release assay (IGRA) and diagnostic value in non-small cell lung cancer (NSCLC) patients.
Xu Y; Zhang Q; Chen Z; Yang S; Chen H; Xiao X; Jiang H
BMC Pulm Med; 2024 Apr; 24(1):174. PubMed ID: 38609918
[TBL] [Abstract] [Full Text] [Related]
9. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective.
Prisciandaro E; Bertolaccini L; Fieuws S; Cara A; Spaggiari L; Huang L; Petersen RH; Ambrogi MC; Sicolo E; Barbarossa A; De Leyn P; Sporici D; Balsamo L; Donlagic A; Gonzalez M; Fuentes-Gago MG; Forcada-Barreda C; Congedo MT; Margaritora S; Belaroussi Y; Thumerel M; Tricard J; Felix P; Lebeda N; Opitz I; De Palma A; Marulli G; Braggio C; Thomas PA; Mbadinga F; Baste JM; Sayan B; Yildizeli B; Van Raemdonck DE; Weder W; Ceulemans LJ
Eur J Cardiothorac Surg; 2024 Mar; 65(4):. PubMed ID: 38579246
[TBL] [Abstract] [Full Text] [Related]
10. A population study comparing tracheal and lung adenoid cystic carcinoma.
Gu Y; Lai S; Wang Y; Yang J; Zhou P; Chen T
Cancer Med; 2024 Apr; 13(7):e7158. PubMed ID: 38572933
[TBL] [Abstract] [Full Text] [Related]
11. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
12. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
[TBL] [Abstract] [Full Text] [Related]
13. Isothermal strand displacement polymerase reaction (ISDPR)-assisted microchip electrophoresis for highly sensitive detection of cancer associated microRNAs.
Chen J; Zhang J; Xie Q; Chu Z; Lu Y; Zhang F; Wang Q
Anal Chim Acta; 2024 Apr; 1300():342469. PubMed ID: 38521570
[TBL] [Abstract] [Full Text] [Related]
14. Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma.
Zhang X; Xiao Q; Zhang C; Zhou Q; Xu T
J Cell Mol Med; 2024 Apr; 28(8):e18262. PubMed ID: 38520221
[TBL] [Abstract] [Full Text] [Related]
15. Clinical Management of Patients with Non-Small Cell lung cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
[TBL] [Abstract] [Full Text] [Related]
16. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
17. Vacuum bell therapy for pectus excavatum: a retrospective study.
Lei W; Shao M; Hu Y; Cao J; Han W; Wang R; Fei Q; Zou J; Yi J; Cheng Z; Liu W
BMC Pediatr; 2024 Mar; 24(1):173. PubMed ID: 38461230
[TBL] [Abstract] [Full Text] [Related]
18. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract] [Full Text] [Related]
19. Endostar acts as a pneumonitis protectant in patients with locally advanced non-small cell lung cancer receiving concurrent chemoradiotherapy.
Chen K; Li S; Chen M; Jin Z; Sun X; Zhou S; Yang H
BMC Cancer; 2024 Feb; 24(1):257. PubMed ID: 38395838
[TBL] [Abstract] [Full Text] [Related]
20. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection.
Jiang MQ; Qian LQ; Shen YJ; Fu YY; Feng W; Ding ZP; Han YC; Fu XL
Neoplasia; 2024 Apr; 50():100979. PubMed ID: 38387107
[TBL] [Abstract] [Full Text] [Related]
[Next]
